ribavirin has been researched along with Diabetic Retinopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Huang, Y; Wu, S; Yang, Y; Yin, S | 1 |
| Midena, E; Noventa, F; Sebastiani, G; Tempesta, D; Vujosevic, S | 1 |
| Cuthbertson, FM; Davies, M; McKibbin, M | 1 |
1 review(s) available for ribavirin and Diabetic Retinopathy
| Article | Year |
|---|---|
[Diabetic retinopathy induced by PEG-IFN-alpha2a plus ribavirin in chronic hepatitis C: a literature review].
Topics: Antiviral Agents; Diabetic Retinopathy; Drug Combinations; Hepatitis C, Chronic; Humans; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2015 |
2 other study(ies) available for ribavirin and Diabetic Retinopathy
| Article | Year |
|---|---|
Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening.
Topics: Adult; Antiviral Agents; Diabetic Retinopathy; Diagnostic Techniques, Ophthalmological; Drug Monitoring; Female; Health Care Costs; Hepatitis C, Chronic; Humans; Hypertension; Hypertensive Retinopathy; Interferon alpha-2; Interferon-alpha; Longitudinal Studies; Male; Mass Screening; Metabolic Syndrome; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors | 2012 |
Is screening for interferon retinopathy in hepatitis C justified?
Topics: Adult; Aged; Antiviral Agents; Diabetic Retinopathy; Drug Therapy, Combination; Female; Fluorescein Angiography; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Remission, Spontaneous; Retinal Diseases; Retinal Hemorrhage; Ribavirin | 2004 |